Blogging Capital Patents San Diego 
Both Sides of the Table
OCTOBER 19, 2009
On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.
Xconomy
DECEMBER 14, 2018
The patent holder, the University of Toronto, gave companies the right to manufacture insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version. In the nearly 100 years since insulin’s discovery, no generic version has become available in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JUNE 3, 2016
Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). billion acquisition of San Diego’s Auspex Pharmaceuticals last year.
Xconomy
MARCH 17, 2017
I hit the airwaves Friday morning to talk venture capital, startups, self-driving cars, and March Madness. Stocks and Jocks , a Chicago-based weekday business and sports talk radio program, invited me on the show to share my thoughts on some of the latest trends in the startup world. I also made some biased predictions about.
Xconomy
JANUARY 25, 2019
After guiding the CRISPR-Cas9 genome-editing startup from scientific breakthrough toward the development of a potential cutting-edge medicine, slogging victoriously through a legendary patent fight , and reaching the cusp of an historic clinical trial , the well-traveled Bosley is cutting out, the company said Tuesday.
Xconomy
DECEMBER 9, 2016
—arguments from both sides of the epic CRISPR patent fight. President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem to think much of the regulatory process. And a trio of judges met to hear brief—can we say edited?—arguments
Xconomy
MAY 30, 2016
What, I think, is the first technology-based, early-stage venture capital fund anywhere, American Research and Development , was founded between Georges Doriot at Harvard Business School and Karl Compton, who was president of MIT at the time. It basically helped invent the ultra-filtration field. Then it got acquired by Millipore.
Expert insights. Personalized for you.
274 
Let's personalize your content